AEON Biopharma Announces $15M Financing Transaction And Termination Of Forward Purchase Agreements
AEON Biopharma Announces $15M Financing Transaction And Termination Of Forward Purchase Agreements
永旺生物製藥宣佈1500萬美元融資交易並終止遠期購買協議
-- Termination of the Forward Purchase Agreements simplifies AEON's capitalization structure --
--遠期購買協議的終止簡化了永旺的資本結構——
-- AEON to expand its Board of Directors with appointment of candidate selected by its strategic partner following full funding of transaction --
— 永旺將在爲交易提供全額資金後任命其戰略伙伴選出的候選人，從而擴大其董事會——
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。